These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 4597989)
61. Fatal aplastic anemia and chloramphenicol. Clarke WT Can Med Assoc J; 1967 Sep; 97(13):815. PubMed ID: 6050902 [No Abstract] [Full Text] [Related]
62. The thalidomide embryopathy. An analysis from the UK. Quibell EP Practitioner; 1981 May; 225(1355):721-6. PubMed ID: 7291126 [No Abstract] [Full Text] [Related]
63. Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. Feinstein AR Clin Pharmacol Ther; 1974 Jul; 16(1):110-23. PubMed ID: 4843239 [No Abstract] [Full Text] [Related]
64. Concordance for drug-induced aplastic anemia in identical twins. Nagao T; Mauer AM N Engl J Med; 1969 Jul; 281(1):7-11. PubMed ID: 5785754 [No Abstract] [Full Text] [Related]
65. [Significance of age, sex, kidney function, atopy and number of prescriptions for the occurrence of adverse drug reactions, studied by multivariate statistical methods. Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB)]. Hoigné R; Sollberger J; Zoppi M; Müller U; Hess T; Fritschy D; Stocker F; Maibach R Schweiz Med Wochenschr; 1984 Dec; 114(49):1854-7. PubMed ID: 6515386 [TBL] [Abstract][Full Text] [Related]
66. Drug usage and adverse drug reactions in paediatric patients. Whyte J; Greenan E Acta Paediatr Scand; 1977 Nov; 66(6):767-75. PubMed ID: 920170 [TBL] [Abstract][Full Text] [Related]
67. The clinical significance and importance of drug interactions. Prescott LF Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1562-7. PubMed ID: 611880 [No Abstract] [Full Text] [Related]
68. [Detection and quantification of adverse reactions on the embryo and the fetus: studies and registries of congenital malformations]. Laporte JR; Diogene E; Aragón C; Vidal X Med Clin (Barc); 1986 Jan; 86(1):31-5. PubMed ID: 3959625 [No Abstract] [Full Text] [Related]
69. [On the liability of the physician in the prescription of drugs, especially contergan]. Trube-Becker E Dtsch Z Gesamte Gerichtl Med; 1966; 57(1):45-55. PubMed ID: 5987937 [No Abstract] [Full Text] [Related]
70. Adverse drug reactions leading to hospitalization in children. McKenzie MW; Marchall GL; Netzloff ML; Cluff LE J Pediatr; 1976 Sep; 89(3):487-90. PubMed ID: 986429 [TBL] [Abstract][Full Text] [Related]
71. [Panmyelopathy (aplastic anemia) caused by drugs and other chemical agents]. Wijnja L; Nieweg HO Tijdschr Ziekenverpl; 1967 Oct; 20(19):656-61. PubMed ID: 5186242 [No Abstract] [Full Text] [Related]
72. [Aplastic anemia following chloramphenicol]. Bar-Haim Y; Sadan N Harefuah; 1974 Feb; 86(4):197-9. PubMed ID: 4828260 [No Abstract] [Full Text] [Related]
73. Computer analysis of epidemiologic data on effect of drugs on hospital patients. Slone D; Gaetano LF; Lipworth L; Shapiro S; Lewis GP; Jick H Public Health Rep (1896); 1969 Jan; 84(1):39-52. PubMed ID: 4974707 [No Abstract] [Full Text] [Related]
75. [Questions on the monitoring of drug consumption at the 7th International pharmaceutical Congress held in Paris, July 16-21, 1978]. Stika L Cesk Zdrav; 1979 Jul; 27(7):320-4. PubMed ID: 36993 [No Abstract] [Full Text] [Related]
76. Adverse drug reactions: the need for detection and control. Cluff LE Am J Epidemiol; 1971 Nov; 94(5):405-8. PubMed ID: 5120538 [No Abstract] [Full Text] [Related]